Analyst consensus rating
Zymeworks Analyst Rating: Strong Buy
Direct answer
Zymeworks's consensus rating is Strong Buy.
14 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $41.21.
Forecast evidence checked October 17, 2026.
Get free Zymeworks email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $25.03
- Average price target
- $41.21
- High price target
- $60.00
- Low price target
- $32.00
- Low target gap
- +27.8%
- Target upside
- +64.7%
- High target gap
- +139.7%
- Target range width
- 111.9%
- Consensus rating
- Strong Buy
- Analysts
- 14
- Evidence date
- October 17, 2026
- Valid through
- October 24, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Zymeworks?
Zymeworks has a verified Strong Buy consensus. The same dataset has an average price target of $41.21.
How far are Zymeworks's low and high targets from the recorded price?
The low target implies +27.8%, while the high target implies +139.7%.
How many analysts are included in Zymeworks's consensus?
The verified consensus includes 14 analysts.
How is Zymeworks's target upside or downside calculated?
The average target of $41.21 is divided by the recorded price of $25.03, then one is subtracted to produce +64.7%. This does not guarantee a future return.
When was Zymeworks's analyst forecast verified?
The data was verified on 2026-10-17. The dataset is valid through 2026-10-24.